<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR1800014246</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2018-01-01</date_registration>
      <primary_sponsor>Beijing Friendship Hospital affiliated to Capital Medical University</primary_sponsor>
      <public_title>Efficaay of microneedling plus mixed growth factors solutions derived from human mesenchymal stem cell for chloasma</public_title>
      <acronym />
      <scientific_title>Efficacy of microneedling plus mixed growth factors solutions derived from human mesenchymal stem cell for chloasma: a Randomized, Controlled, Blinded Split-Fcae Study </scientific_title>
      <Scientific_acronym />
      <date_enrolment>2018-01-01</date_enrolment>
      <type_enrolment />
      <target_size>Two groups:25;</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=24357</url>
      <study_type>Interventional study</study_type>
      <study_design>Randomized parallel controlled trial</study_design>
      <phase>New Treatment Measure Clinical Study</phase>
      <hc_freetext>Chloasma</hc_freetext>
      <i_freetext>Two groups:microneedling versus microneedling plus mixed growth factors solutions;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan>Yes</results_IPD_plan>
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Zhuo Fenglin</firstname>
        <middlename />
        <lastname />
        <address>95 Yong'an Road, Xicheng District, Beijing, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 15910895068</telephone>
        <email>zflsunny@hotmail.com</email>
        <affiliation>Beijing Friendship Hospital affiliated to Capital Medical University</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Zhuo Fenglin</firstname>
        <middlename />
        <lastname />
        <address>95 Yong'an Road, Xicheng District, Beijing, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 15910895068</telephone>
        <email>zflsunny@hotmail.com</email>
        <affiliation>Beijing Friendship Hospital affiliated to Capital Medical University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. Aged 30-60 years old male and female;
2. 2 deputy chief physician diagnosed chloasma;
3. Facial skin intact, no obvious inflammation, ulceration, exudation;
4. No facial filler such as hyaluronic acid or laser/light treatment;
5. No oral steroids, collagen powder/liquid, or topical hyaluronic acid used in the last 3 months;
6. No skin whitening products in the last 2 weeks.</inclusion_criteria>
      <agemin>35</agemin>
      <agemax>60</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. Pregnant or in breast-feeding peroid;
2. Facial dermatitis patients;
3. Allergic to trial medcine or its ingredient;
4. Have severe cardiovascular, cerebrovascular, renal, hepatic or hematopoietic disease;
5. Poor coagulation function;
6. Taking part in other clinical trials;
7. People that researchers believe they are not suitable to participate in the study.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>skin pores;skin texture;skin wrinkle;UV spots;Black brown spots;Erythema;skin hydration;skin transepidermal water loss;skin elasticity;skin melanin index;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome />
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>self-financing</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-11-13</approval_date>
        <contact_name>Li Yue</contact_name>
        <contact_address />
        <contact_phone>86-13661202501</contact_phone>
        <contact_email>13661202501@163.com</contact_email>
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>